3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Non Small Cell Lung Cancer Metastatic
1
Lung Neoplasms
1
Interventions
osimertinib
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Non Small Cell Lung Cancer Metastatic
×
osimertinib
×
Clear all
NCT03133546
2026-02-06
BOOSTER
ETOP IBCSG Partners Foundation
Phase 2
Completed
155 enrolled
23 charts